Full TextClose
Please select the full text article you wish to view:
Medline ® Abstract for Reference 8
of 'Chronic inflammatory demyelinating polyneuropathy: Etiology, clinical features, and diagnosis'
8
TI
Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.
AU
Peltier AC, Donofrio PD
SO
Semin Neurol. 2012;32(3):187.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is the most common treatable chronic autoimmune neuropathy. Multiple diagnostic criteria have been established, with the primary goal of identifying neurophysiologic hallmarks of acquired demyelination. Treatment modalities have expanded to include numerous immunomodulatory therapies, although the best evidence continues to be for corticosteroids, plasma exchange, and intravenous immunoglobulin (IVIg). This review describes the pathology, epidemiology, pathogenesis, diagnosis, and treatment of CIDP.
AD
Department of Neurology, Vanderbilt Medical Center, Medical Center North, Nashville, Tennessee.
PMID